Fesilty Kit
Product Images NDC 13533-502

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fesilty (NDC 13533-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Water (Wfi Label 3)

Label of Sterile Water for Injection USP, 50 mL single-dose container by Grifols, for reconstitution of an accompanying product. The label notes the product is nonpyrogenic and free of antimicrobial agents or other substances. Manufacturer information is Laboratorios Grifols S.A., Barcelona, Spain.*

FDA Label Image

Figures 1-9 (Figures1 9)

An instructional illustration showing nine figures detailing the preparation steps for FESILTY kit containing fibrinogen, human-chmt. It depicts opening bottles labeled 'WATER 1' and 'FESILTY 2', using a cup and transferring liquid between bottles, mixing by inversion, and finally connecting the FESILTY bottle to a syringe. The steps guide correct reconstitution and handling of the product components.*

FDA Label Image

Inner Carton (Inner Carton 7)

Flat packaging template for FESILTY fibrinogen, human-chmt kit by Grifols USA LLC. The box design includes simple assembly lines and a panel with shortened illustrated mixing and preparation instructions for the product. No dosage strength or package count is visible in the image.*

FDA Label Image

Outer Carton (Outer Carton 10)

FESILTY 1 g vial, fibrinogen, human-chmt lyophilized powder kit by Grifols USA LLC. The label includes dosing and reconstitution information, storage instructions, and warnings about the product being prepared from large pools of human plasma. The product is for intravenous use only and is Rx only. Packaging displays NDC 13533-502-01 and manufacturing details for Grifols Therapeutics LLC and Biotest AG.*

FDA Label Image

Label (Product Label 9)

FESILTY 1 g vial label for fibrinogen, human-chmt lyophilized powder, a plasma derivative kit by Grifols USA LLC. The label includes storage instructions, dosage and administration notes, product codes, and batch identification details. The design features prominently the brand and generic names, dosage strength, and company logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.